ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

Therapeutic Vaccine May Fight Pancreatic Cancer

February 23, 2007

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

In Brief: Gilbert Fletcher, Father of Modern Radiotherapy, Dead At 80 In Houston; Built First Cobalt-60 Unit

January 24, 1992

Clinical Nutrition Academic Award Concept Approved

October 4, 1985